Scientific Publications

You will find below some publications which appeared interesting to us. This list is not exhaustive but it will enable you to begin your research.

Nutritional yeast

  • STEPANIAK J., 1997, The Nutritional Yeast Cookbook: Recipes Using Red Star Vegetarian Support Formula Flakes; Summertown (U.S.A.): Book Publishing Compagny. 143 p. ISBN: 978-1-57067-038-1.
  • WHO/FAO/UNU, 2007, Protein and amino acid requirements in human nutrition, In: WHO technical report Series 935, p. 245. Download the document PDF

Saccharomyces cerevisiae var. Boulardii

  • AFSSA (French Food Safety Agency), 2005, Effects of probiotics and prebiotics on flora and immunity in adults. ISBN: 978-2-11-095439-8. Download the document PDF
  • BIELECKA M., 2007, Probiotics in Food, In: SIKORSKI Z.E. (Ed.) Chemical and Functional Properties of Food Components 3rd Edition; New-York (U.S.A.): CRC Press LLC. p 413-426. ISBN: 978-0-8493-9675-5.
  • BILLOO A.G., MEMON M.A., KHASKHELI S.A., MURTAZA G., IQBAL K., SAEED SHEKHANI M., SIDDIQI A.Q., 2006, Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea, In: World Journal of Gastroenterology; volume 12, issue 28, p. 4557-4560.
  • BUTS J.P., 2004, Example of a Medicinal Probiotic: Lyophilised Saccharomyces boulardii, In: RAMBAUD J.C., BUTS J.P., CORTHIER G., FLOURIÉ B. (Eds.) Flore microbienne intestinale; Paris(France): John Libbey Eurotext. p 221-244. ISBN: 978-2-7420-0585-7.
  • D'SOUZA A.L., RAJKUMAR C., COOKE J., BULPITT C.J., 2002, Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis, In: BMJ; volume 324, issue 7350, p. 1361. Review.
  • GEDEK B.R., 1999, Adherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii In: Mycoses; volume 42, issue 4, p 261-264.


  • EFSA, 2008, Selenium-enriched yeast as source for selenium added for nutritional purposes in foods for particular nutritional uses and foods (including food supplements) for the general population - Scientific Opinion of the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food, In: The EFSA Journal n° 766, 1-42. Opinion available at
  • INSTITUTE OF MEDICINE, FOOD AND NUTRITION BOARD, 2000, Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC (U.S.A.): National Academy Press. ISBN: 978-0-309-06935-9. Table available on the U.S. Office of Dietary Supplements’ website.
  • RAYMAN M.P., 2000, The importance of selenium to human health, In: The Lancet; volume 356, issue 9225, p 233-241.
  • THE COMMISSION OF THE EUROPEAN COMMUNITIES, 2008, Directive 2008/100/EC amending Council Directive 90/496/EEC on nutrition labelling for foodstuffs as regards recommended daily allowances, energy conversion factors and definitions; Official Journal of the European Union L 285, p. 9-12.


  • AKRAMIENE D, KONDROTAS A, DIDZIAPETRIENE J, KEVELAITIS E., 2007, Effects of beta-glucans on the immune system, In: Medicina (Kaunas,Lithuania); volume 43, issue 8, p. 597-606. Review.
  • CODEX ALIMENTARIUS, 2009, ALINORM 09/32/26: Report of the thirtieth session of the Codex Committee on nutrition and foods for special dietary uses; Appendix II p. 46. Download the document PDF
  • CZOP J.K., 1986, The Role of β-Glucan Receptors on Blood and Tissue Leukocytes in Phagocytosis and Metabolic Activation, In: Pathology and immunopathology research; volume 5, issue 3-5, p. 286-296.
  • LEHNE G., HANEBERG B., GAUSTAD P., JOHANSEN P.W., PREUS H., ABRAHAMSEN T.G., 2006, Oral administration of a new soluble branched beta-1,3-D-glucan is well tolerated and can lead to increased salivary concentrations of immunoglobulin A in healthy volunteers, In: Clinical and experimental immunology; volume 143, issue 1, p. 65-69.
  • LI B, ALLENDORF DJ, HANSEN R, MARROQUIN J, DING C, CRAMER DE, YAN J., 2006, Yeast beta-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathway, In: Journal of Immunology; volume 177, issue 3, p. 1661-1669.
  • ZEKOVIĆ D.B., KWIATKOWSKI S., VRVIĆ M.M., JAKOVLJEVIĆ D., MORAN C.A., 2005, Natural and modified (1→3)-beta-D-glucans in health promotion and disease alleviation, In: Critical reviews in biotechnology; volume 25, issue 4, p. 205-230. Review.

Yeast Peptides

  • HALTON T.L., HU F.B., 2004, The effects of high protein diets on thermogenesis, satiety and weight loss: a critical review, In: Journal of the American College of Nutrition; volume 23, issue 5, p. 373-385. Review.
  • NEGRO M., GIARDINA S., MARZANI B., MARZATICO F., 2008, Branched-chain amino acid supplementation does not enhance athletic performance but affects muscle recovery and the immune system, In: The Journal of Sports Medicine and Physical Fitness; volume 48, issue 3, p. 347-351. Review.
  • SHIMOMURA Y., YAMAMOTO Y., BAJOTTO G., SATO J., MURAKAMI T., SHIMOMURA N., KOBAYASHI H., MAWATARI K., 2006, Nutraceutical effects of branched-chain amino acids on skeletal muscle, In: The Journal of Nutrition; volume 136, issue 2, p. 529S-532S.
  • WHO/FAO/UNU Expert consultation, 2007, Protein and amino acid requirements in human nutrition, In: WHO technical report Series 935, p. 245.

Yeast Allergy / Candida

Yeast allergy

  • BALDO B.A., BAKER R.S., 1988, Inhalant allergies to fungi: reactions to bakers’ yeast (Saccharomyces cerevisiae) and identification of bakers’ yeast enolase as an important allergen, In: International archives of allergy and applied immunology; volume 86, issue 2, p. 201-208.
  • KORTEKANGAS-SAVOLAINEN O., SAVOLAINEN J., LANTTO R., KALIMO K., 1994, Immediate hypersensitivity to bakery, brewery and wine products in yeast-sensitive atopic dermatitis patients, In: Clinical and experimental allergy; volume 24, issue 9, p. 836-842.
  • SIMON-NOBBE B., PROBST G., KAJAVA A.V., OBERKOFLER H., SUSANI M., CRAMERI R., FERREIRA F., EBNER C., BREITENBACH M., 2000, IgE-binding epitopes of enolase, a class of highly conserved fungal allergens, In: The Journal of allergy and clinical immunology; volume 106, issue 5, p. 887-895.


  • BUDKA D., 2007, The Candida Confusion - The failures of conventional and complementary medicine. London (United Kingdom): DBR Publication. 64 p. ISBN: 978-0-9557205-0-5. Document available at
  • DUCLUZEAU R., BENSAADA M., 1982, Comparative effect of a single or continuous administration of "Saccharomyces boulardii" on the establishment of various strains of "candida" in the digestive tract of gnotobiotic mice, In: Annales de Microbiologie (Paris); volume 133, issue 3, p. 491-501 (Article in French).
  • JAWHARA S., POULAIN D., 2007, Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitis, In: Medical Mycology; volume 45, issue 8, p. 691-700.